Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III study
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | JURCZAK, W. | |
dc.contributor.author | MOREIRA, I. | |
dc.contributor.author | GOVINDBABU, K. Setty | |
dc.contributor.author | MUNHOZ, E. | |
dc.contributor.author | ECHEVESTE, M-A. | |
dc.contributor.author | GIRI, P. | |
dc.contributor.author | CASTRO, N. | |
dc.contributor.author | PEREIRA, J. | |
dc.contributor.author | LUIZA, A. | |
dc.contributor.author | ALEXEEV, S. | |
dc.contributor.author | OSMANOV, D. | |
dc.contributor.author | ZHU, P. | |
dc.contributor.author | ALEXANDROVA, S. | |
dc.contributor.author | ZUBEL, A. | |
dc.contributor.author | HARLIN, O. | |
dc.contributor.author | AMERSDORFFER, J. | |
dc.date.accessioned | 2018-02-22T17:36:55Z | |
dc.date.available | 2018-02-22T17:36:55Z | |
dc.date.issued | 2017 | |
dc.description.conferencedate | SEP 08-12, 2017 | |
dc.description.conferencelocal | Madrid, SPAIN | |
dc.description.conferencename | 42nd European-Society-for-Medical-Oncology Congress (ESMO) | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | Hexal AG | |
dc.identifier.citation | ANNALS OF ONCOLOGY, v.28, suppl.5, 2017 | |
dc.identifier.eissn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/25089 | |
dc.language.iso | eng | |
dc.publisher | OXFORD UNIV PRESS | |
dc.relation.ispartof | Annals of Oncology | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright OXFORD UNIV PRESS | |
dc.subject.wos | Oncology | |
dc.title | Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: Extended results of ASSIST-FL, a confirmatory phase III study | |
dc.type | conferenceObject | |
dc.type.category | meeting abstract | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.country | Rússia | |
hcfmusp.affiliation.country | Israel | |
hcfmusp.affiliation.country | Austrália | |
hcfmusp.affiliation.country | Espanha | |
hcfmusp.affiliation.country | Índia | |
hcfmusp.affiliation.country | Portugal | |
hcfmusp.affiliation.country | Polônia | |
hcfmusp.affiliation.country | Alemanha | |
hcfmusp.affiliation.countryiso | pl | |
hcfmusp.affiliation.countryiso | pt | |
hcfmusp.affiliation.countryiso | in | |
hcfmusp.affiliation.countryiso | es | |
hcfmusp.affiliation.countryiso | au | |
hcfmusp.affiliation.countryiso | il | |
hcfmusp.affiliation.countryiso | ru | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.affiliation.countryiso | de | |
hcfmusp.author.external | JURCZAK, W.:Jagiellonian Univ, Dept Hematol, Krakow, Poland | |
hcfmusp.author.external | MOREIRA, I.:Portuguese Inst Oncol Porto Francisco Gentil, Dept Oncohaematol, Oporto, Portugal | |
hcfmusp.author.external | GOVINDBABU, K. Setty:Curie Ctr Oncol, Dept Med Oncol, Bangalore, Karnataka, India; Kidwai Mem Inst Oncol, Bangalore, Karnataka, India | |
hcfmusp.author.external | MUNHOZ, E.:Hosp Erasto Gaertner, Dept Clin Oncol, Curitiba, Parana, Brazil | |
hcfmusp.author.external | ECHEVESTE, M-A.:Hosp Donostia, Dept Hematol, San Sebastian, Spain | |
hcfmusp.author.external | GIRI, P.:Royal Adelaide Hosp, Dept Hematol, Adelaide, SA, Australia | |
hcfmusp.author.external | CASTRO, N.:Hosp Canc Barretos, Dept Hematol, Sao Paulo, Brazil | |
hcfmusp.author.external | LUIZA, A.:Med Ctr Galil, Inst Hematol, Naharyia, Israel | |
hcfmusp.author.external | ALEXEEV, S.:Res Oncol Inst Rosmed Technol, Dept Hematol, St Petersburg, Russia | |
hcfmusp.author.external | OSMANOV, D.:Russian Acad Med Sci, Blokhin Canc Res Ctr, Dept Chemotherapy Hematol Malignancies, Moscow, Russia | |
hcfmusp.author.external | ZHU, P.:Sandoz Inc, Clin Pharmacol, Princeton, NJ USA | |
hcfmusp.author.external | ALEXANDROVA, S.:Sandoz Inc, Biostat, Princeton, NJ USA | |
hcfmusp.author.external | ZUBEL, A.:Hexal AG, Med Affairs, Holzkirchen, Germany | |
hcfmusp.author.external | HARLIN, O.:Hexal AG, Med Affairs, Holzkirchen, Germany | |
hcfmusp.author.external | AMERSDORFFER, J.:Hexal AG, Med Affairs, Holzkirchen, Germany | |
hcfmusp.contributor.author-fmusphc | JULIANA PEREIRA | |
hcfmusp.description.issue | suppl 5 | |
hcfmusp.description.volume | 28 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000411324002230 | |
hcfmusp.publisher.city | OXFORD | |
hcfmusp.publisher.country | ENGLAND | |
relation.isAuthorOfPublication | 58959854-e2e3-4246-9a9e-ca4b771aa16f | |
relation.isAuthorOfPublication.latestForDiscovery | 58959854-e2e3-4246-9a9e-ca4b771aa16f |